B Isemann

437 total citations
10 papers, 309 citations indexed

About

B Isemann is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, B Isemann has authored 10 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Pharmacology. Recurrent topics in B Isemann's work include Neonatal Health and Biochemistry (6 papers), Prenatal Substance Exposure Effects (6 papers) and Maternal Mental Health During Pregnancy and Postpartum (3 papers). B Isemann is often cited by papers focused on Neonatal Health and Biochemistry (6 papers), Prenatal Substance Exposure Effects (6 papers) and Maternal Mental Health During Pregnancy and Postpartum (3 papers). B Isemann collaborates with scholars based in United States and United Kingdom. B Isemann's co-authors include Henry T. Akinbi, Jareen Meinzen‐Derr, Jason R. Wiles, Eric Mueller, Laura P. Ward, Alexander A. Vinks, Vivek Narendran, Scott L. Wexelblatt, Eric S. Hall and Tomoyuki Mizuno and has published in prestigious journals such as The Journal of Pediatrics, Journal of Parenteral and Enteral Nutrition and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

B Isemann

10 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Isemann United States 9 242 136 110 50 41 10 309
Kathryn Johnson United Kingdom 9 241 1.0× 154 1.1× 78 0.7× 28 0.6× 33 0.8× 23 332
I. Pineda Spain 5 99 0.4× 300 2.2× 48 0.4× 14 0.3× 76 1.9× 5 466
Jamil Pedro de Siqueira Caldas Brazil 12 179 0.7× 72 0.5× 42 0.4× 141 2.8× 80 2.0× 32 330
Laura P. Ward United States 12 209 0.9× 93 0.7× 66 0.6× 58 1.2× 152 3.7× 38 375
Charlotte Palme‐Kilander Sweden 9 117 0.5× 31 0.2× 102 0.9× 236 4.7× 39 1.0× 14 355
Wesley Jackson United States 8 98 0.4× 40 0.3× 29 0.3× 161 3.2× 64 1.6× 23 242
Akhil Deshpandey Canada 6 199 0.8× 183 1.3× 73 0.7× 249 5.0× 102 2.5× 6 457
Jasmeet S. Mokha United States 6 85 0.4× 194 1.4× 11 0.1× 13 0.3× 42 1.0× 10 365
Ana Gimeno Spain 6 232 1.0× 37 0.3× 221 2.0× 409 8.2× 41 1.0× 10 560
John Wimmer United States 9 266 1.1× 21 0.2× 160 1.5× 300 6.0× 64 1.6× 21 520

Countries citing papers authored by B Isemann

Since Specialization
Citations

This map shows the geographic impact of B Isemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Isemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Isemann more than expected).

Fields of papers citing papers by B Isemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Isemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Isemann. The network helps show where B Isemann may publish in the future.

Co-authorship network of co-authors of B Isemann

This figure shows the co-authorship network connecting the top 25 collaborators of B Isemann. A scholar is included among the top collaborators of B Isemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Isemann. B Isemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Isemann, B, et al.. (2017). Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(7). 840–848. 21 indexed citations
3.
Barhight, Matthew, et al.. (2017). Nephrotoxic Medications and Associated Acute Kidney Injury in Very Low Birth Weight Infants.. PubMed. 4(4). 14 indexed citations
4.
Hall, Eric S., B Isemann, Scott L. Wexelblatt, et al.. (2015). A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome. The Journal of Pediatrics. 170. 39–44.e1. 46 indexed citations
5.
Wiles, Jason R., B Isemann, Tomoyuki Mizuno, et al.. (2015). Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study. The Journal of Pediatrics. 167(6). 1214–1220.e3. 40 indexed citations
6.
Isemann, B, Eric Mueller, Vivek Narendran, & Henry T. Akinbi. (2014). Impact of Early Sodium Supplementation on Hyponatremia and Growth in Premature Infants. Journal of Parenteral and Enteral Nutrition. 40(3). 342–349. 39 indexed citations
7.
Wiles, Jason R., B Isemann, Laura P. Ward, Alexander A. Vinks, & Henry T. Akinbi. (2014). Current Management of Neonatal Abstinence Syndrome Secondary to Intrauterine Opioid Exposure. The Journal of Pediatrics. 165(3). 440–446. 35 indexed citations
8.
Isemann, B, et al.. (2012). Effect of heparin and other factors associated with complications of peripherally inserted central venous catheters in neonates. Journal of Perinatology. 32(11). 856–860. 18 indexed citations
9.
Isemann, B, Jareen Meinzen‐Derr, & Henry T. Akinbi. (2010). Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. Journal of Perinatology. 31(1). 25–29. 68 indexed citations
10.
Isemann, B, et al.. (1996). Optimal Gentamicin Therapy in Preterm Neonates Includes Loading Doses and Early Monitoring. Therapeutic Drug Monitoring. 18(5). 549–555. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026